Insiders · Profile

Olwill Shane

Chief Development Officer at PALVELLA THERAPEUTICS. Filing since 30 Aug 2021. CIK 0001875416

Company
Date
Role
Action
Shares
Amount
Of holding
30 Aug 2021
Chief Development Officer
Sold, plan not stated
38,400
$196.38K
89.2%
1 decision on file.